Known targets — ChEMBL curated mechanism
ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG
The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2181354 | 0.93 | — | — | |
| SCHEMBL15422 | 0.93 | — | — | |
| SCHEMBL3960199 | 0.93 | — | — | |
| SCHEMBL6712915 | 0.86 | — | — | |
| Water SCHEMBL9289518 | 0.86 | — | — | |
| SCHEMBL23926390 | 0.86 | — | — | |
| Ammonia Solution, Strong SCHEMBL1070242 | 0.86 | ALDH1A1 (0.33) | — | |
| SCHEMBL5556361 | 0.86 | — | — | |
| Ethylene SCHEMBL11040177 | 0.86 | — | — | |
| Ammonia Solution, Strong SCHEMBL11108859 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11542255-B2 | Sulfonylureas and sulfonylthioureas as NLRP3 inhibitors | INFLAZOME LIMITED (IE) | 2023-01-03 | — | — | US | disclosed |
| US-11529611-B2 | Composition for forming absorption-desorption sheet, absorption-desorption sheet including the composition, and method of preparing the absorption-desorption sheet | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2022-12-20 | — | — | US | disclosed |
| EP-4013762-A1 | MACROCYCLIC SULFONYLAMIDE DERIVATIVES USEFUL AS NLRP3 INHIBITORS | Inflazome Limited (IE) | 2022-06-22 | — | — | EP | disclosed |
| US-20210130329-A1 | SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS | INFLAZOME LIMITED (IE) | 2021-05-06 | — | — | US | disclosed |
| WO-2021032588-A1 | MACROCYCLIC SULFONYLAMIDE DERIVATIVES USEFUL AS NLRP3 INHIBITORS | INFLAZOME LIMITED (IE) | 2021-02-25 | — | — | WO | disclosed |
| EP-3668842-A1 | SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS | Inflazome Limited (IE) | 2020-06-24 | — | — | EP | disclosed |
| WO-2019034692-A1 | SULFONYLUREAS AND SULFONYLTHIOUREAS AS NLRP3 INHIBITORS | INFLAZOME LIMITED (IE) | 2019-02-21 | — | — | WO | disclosed |
| US-20180178195-A1 | COMPOSITION FOR FORMING ABSORPTION-DESORPTION SHEET, ABSORPTION-DESORPTION SHEET INCLUDING THE COMPOSITION, AND METHOD OF PREPARING THE ABSORPTION-DESORPTION SHEET | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2018-06-28 | — | — | US | disclosed |
| CN-105308041-B | Preparation method for ixabepilone and intermediate thereof | 台湾神隆股份有限公司 | 2018-06-01 | — | — | CN | disclosed |
| EP-3099299-A1 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | Auspex Pharmaceuticals, Inc. (US) | 2016-12-07 | — | — | EP | disclosed |
| CN-105308041-A | Preparation method for ixabepilone and intermediate thereof | SCINOPHARM TAIWAN LTD | 2016-02-03 | — | — | CN | disclosed |
| EP-2951178-A1 | BENZOQUINOLONE INHIBITORS OF VMAT2 | Auspex Pharmaceuticals, Inc. (US) | 2015-12-09 | — | — | EP | disclosed |
| EP-2934149-A1 | C6-AZASPIRO IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2015-10-28 | — | — | EP | disclosed |
| WO-2015112707-A1 | BENZOQUINOLINE INHIBITORS OF VESICULAR MONOAMINE TRANSPORTER 2 | AUSPEX PHARMACEUTICALS, INC. (US) | 2015-07-30 | — | — | WO | disclosed |
| WO-2014120654-A1 | BENZOQUINOLONE INHIBITORS OF VMAT2 | AUSPEX PHARMACEUTICALS, INC. (US) | 2014-08-07 | — | — | WO | disclosed |
| WO-2014099768-A1 | C6-AZASPIRO IMINOTHIADIAZINE DIOXIDES AS BACE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2014-06-26 | — | — | WO | disclosed |
| EP-2576552-A2 | BENZOQUINOLONE INHIBITORS OF VMAT2 | Aupex Pharmaceutical, Inc. (US) | 2013-04-10 | — | — | EP | disclosed |
| WO-2011153157-A2 | BENZOQUINOLONE INHIBITORS OF VMAT2 | AUSPEX PHARMACEUTICAL, INC. (US) | 2011-12-08 | — | — | WO | disclosed |
| EP-0954553-A1 | LATENT CATALYSTS FOR EPOXY CURING SYSTEMS | THE DOW CHEMICAL COMPANY (US) | 1999-11-10 | — | — | EP | disclosed |
| WO-1998031750-A1 | LATENT CATALYSTS FOR EPOXY CURING SYSTEMS | THE DOW CHEMICAL COMPANY (US) | 1998-07-23 | — | — | WO | disclosed |